PACTR202312573138301尚未招募Unknown
Multicentre, 2-arm, parallel group, assessor blinded, non-inferiority randomised controlled trial with an internal pilot to assess if non-surgeon physicians (NSPs) can effectively perform mesh inguinal hernia repair compared to fully trained surgeons in adult patients with non-complicated inguinal hernia (TIGER)
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 1,782
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Patients older than 18 years (male or female) and less or equal to 60 years
- •Primary inguinal hernia (unilateral) eligible for elective inguinal hernia repair
- •Primary bilateral, but only one side being repaired
- •Written informed consent of patient (signature or a fingerprint)
排除标准
- •Complex inguinal hernias: recurrent, obstructive, or femoral hernias
- •Bilateral inguinal hernias undergoing simultaneous repair
- •Inguinal hernias needing emergent surgical repair (e.g., incarcerated)
- •Patient unable to complete post-operative follow-up
研究者
相似试验
进行中（未招募）
不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks of treatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria CIChronic Idiopathic UrticariaEUCTR2005-000358-65-ITCB PHARMA
进行中（未招募）
不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU)MedDRA version: 8.0Level: LLTClassification code 10009159Chronic Idiopathic UrticariaEUCTR2005-000358-65-DECB Pharma S.A.816
进行中（未招募）
1 期
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU) - CUTEChronic Idiopathic UrticariaEUCTR2005-000358-65-ESCB S.A. Pharma Sector816
进行中（未招募）
不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU)Chronic Idiopathic UrticariaEUCTR2005-000358-65-GBCB S.A.816
进行中（未招募）
不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU)Chronic Idiopathic UrticariaMedDRA version: 8.0Level: LLTClassification code 10009159EUCTR2005-000358-65-BECB S.A. Pharma Sector816